BRPI0407642A - terapia combinada compreendendo um derivado indol pirrol carbazol e um outro agente antitumor - Google Patents

terapia combinada compreendendo um derivado indol pirrol carbazol e um outro agente antitumor

Info

Publication number
BRPI0407642A
BRPI0407642A BRPI0407642-7A BRPI0407642A BRPI0407642A BR PI0407642 A BRPI0407642 A BR PI0407642A BR PI0407642 A BRPI0407642 A BR PI0407642A BR PI0407642 A BRPI0407642 A BR PI0407642A
Authority
BR
Brazil
Prior art keywords
antitumor agent
pyrrol
indole
combination therapy
carbazole derivative
Prior art date
Application number
BRPI0407642-7A
Other languages
English (en)
Inventor
Marina Ciomei
Enrico Pesenti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of BRPI0407642A publication Critical patent/BRPI0407642A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"TERAPIA COMBINADA COMPREENDENDO UM DERIVADO INDOL PIRROL CARBAZOL E UM OUTRO AGENTE ANTITUMOR". A presente invenção refere-se a um processo para tratamento de câncer em um sujeito em necessidade de tal tratamento, o dito processo compreendendo a administração ao paciente de uma quantidade terapeuticamente efetiva de edotecarin junto com capecitabine ou docetaxel.
BRPI0407642-7A 2003-02-21 2004-02-16 terapia combinada compreendendo um derivado indol pirrol carbazol e um outro agente antitumor BRPI0407642A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000317A ITMI20030317A1 (it) 2003-02-21 2003-02-21 Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.
PCT/EP2004/050130 WO2004073719A1 (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent

Publications (1)

Publication Number Publication Date
BRPI0407642A true BRPI0407642A (pt) 2006-03-01

Family

ID=32894164

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407642-7A BRPI0407642A (pt) 2003-02-21 2004-02-16 terapia combinada compreendendo um derivado indol pirrol carbazol e um outro agente antitumor

Country Status (10)

Country Link
EP (1) EP1599210A1 (pt)
JP (1) JP2006518355A (pt)
AR (1) AR043241A1 (pt)
BR (1) BRPI0407642A (pt)
CA (1) CA2516097A1 (pt)
CL (1) CL2004000319A1 (pt)
IT (1) ITMI20030317A1 (pt)
MX (1) MXPA05008879A (pt)
TW (1) TW200500073A (pt)
WO (1) WO2004073719A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2665068C (en) * 2006-10-06 2016-01-05 Bn Immunotherapeutics Inc. Methods for treating cancer with mva

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441026B1 (en) * 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
EP1278518B1 (en) * 2000-02-28 2006-11-08 Pfizer Enterprises SARL Synergistic combination for the treatment of colorectal cancer

Also Published As

Publication number Publication date
EP1599210A1 (en) 2005-11-30
WO2004073719A1 (en) 2004-09-02
TW200500073A (en) 2005-01-01
CA2516097A1 (en) 2004-09-02
AR043241A1 (es) 2005-07-20
CL2004000319A1 (es) 2005-04-22
JP2006518355A (ja) 2006-08-10
ITMI20030317A1 (it) 2004-08-22
MXPA05008879A (es) 2005-10-05

Similar Documents

Publication Publication Date Title
BR0315630A (pt) Administração de combinação de uma indolinona com um agente quimioterapêutico para distúrbios de proliferação celular
NO20071426L (no) Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
HK1120427A1 (en) Anti-glypican-3 antibody
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
CY1112387T1 (el) Θεραπευτικη συνθεση περιεχουσα τουλαχιστον ενα παραγωγο της πυρρολοβενζοδιαζεπινης και φλουδαραβινη
EA200801853A1 (ru) Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
BRPI0517976A (pt) métodos de tratamento
EP1348466A3 (en) Method for treating pain with adenosine-tetraphosphates
TW200633700A (en) Methods of using temozolomide formulation intrathecally in the treatment of cancers
NO20061184L (no) Fremgangsmater og blandinger for behandling av herpes-infeksjoner
EA200801731A1 (ru) Составы и способы лечения тробмоцитемии
NO20064753L (no) Kombinasjonsterapi
NO20076657L (no) Kombinasjonsterapi av cancer med AZD2171 og gemcitabin
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
WO2006109170A3 (en) Combination therapy for treatment of cardiovascular diseases and related conditions
MX2021011289A (es) Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas.
BRPI0407642A (pt) terapia combinada compreendendo um derivado indol pirrol carbazol e um outro agente antitumor
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
WO2011094260A3 (en) Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
DK1488795T3 (da) Midler til behandling af lungecancer
ATE537838T1 (de) Kombinationstherapie mit kloretazin(tm)
BR0308976A (pt) Terapia combinada contra tumores compreendendo derivados de acriloil distamicina substituìda e radioterapia

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.